Literature DB >> 21088175

A diagnostic algorithm for detection of antibodies to influenza A viruses in dogs in Italy (2006-2008).

Paola De Benedictis1, Tara C Anderson, Andrés Perez, Elisabetta Viale, Crispina Veggiato, Silvia Tiozzo Caenazzo, P Cynda Crawford, Ilaria Capua.   

Abstract

Since 2004, there have been several reports of Influenza A virus (FLUAV) infection in dogs. Dogs have been infected with equine influenza H3N8, avian influenza H3N2 and H5N1, and the pandemic H1N1 virus. Because of recent avian and equine influenza outbreaks in Italy, the objectives of the present study were to estimate the level of exposure of Italian dogs to influenza A viruses and to assess a diagnostic algorithm for detection of FLUAV exposure in dogs. Sera collected from 6,858 dogs from 2006 to 2008 were screened in a competitive enzyme-linked immunosorbent assay (cELISA) for antibodies to the highly conserved influenza A nucleoprotein. Samples positive in the cELISA were confirmed by testing in hemagglutination inhibition (HI) and fluorescent antibody test (FAT). Two seropositive dogs had antibodies to H3 hemagglutinin proteins, consistent with exposure to recent canine and equine subtype H3N8 viruses. Using a Bayesian model, the sensitivity and specificity of the cELISA were estimated as 93.98% (probability intervals [PI]: 81.67-99.08%) and 98.71% (PI: 98.43-98.96%), respectively. After accounting for the imperfect sensitivity and specificity of the cELISA, the Bayesian posterior prevalence of FLUAV exposure among tested Italian dogs was 0.5% (PI: 0.1-1.4%). The study results indicate that screening with a cELISA for influenza A nucleoprotein antibody, followed by confirmatory testing with HI and/or FAT, is a highly sensitive and highly specific approach for diagnosing FLUAV exposure in dogs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088175     DOI: 10.1177/104063871002200610

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Evaluation of the immune status of birds and domestic and companion animals for the influenza A virus in Eastern Saudi Arabia.

Authors:  Abdelmohsen Abduallah Alnaeem; Abdulkareem Al-Shabeb; Maged Gomaa Hemida
Journal:  Vet World       Date:  2020-09-23

2.  Genetic characterization of canine influenza A virus (H3N2) in Thailand.

Authors:  Napawan Bunpapong; Nutthawan Nonthabenjawan; Supassama Chaiwong; Ratanaporn Tangwangvivat; Supanat Boonyapisitsopa; Waleemas Jairak; Ranida Tuanudom; Duangduean Prakairungnamthip; Sanipa Suradhat; Roongroje Thanawongnuwech; Alongkorn Amonsin
Journal:  Virus Genes       Date:  2013-10-08       Impact factor: 2.332

3.  Serologic investigation of influenza A virus infection in dogs in Poland.

Authors:  Malgorzata Kwasnik; Marcin Smreczak; Jerzy Rola; Kinga Urbaniak; Wojciech Rozek
Journal:  J Vet Diagn Invest       Date:  2020-03-24       Impact factor: 1.279

4.  Diagnostic performance of the canine influenza A virus subtype H3N8 hemagglutination inhibition assay.

Authors:  Tara C Anderson; P Cynda Crawford; Jacqueline M Katz; Edward J Dubovi; Gabriele Landolt; E Paul J Gibbs
Journal:  J Vet Diagn Invest       Date:  2012-05       Impact factor: 1.279

5.  Serologic evidence of pandemic (H1N1) 2009 infection in dogs, Italy.

Authors:  William G Dundon; Paola De Benedictis; Elisabetta Viale; Ilaria Capua
Journal:  Emerg Infect Dis       Date:  2010-12       Impact factor: 6.883

6.  Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections.

Authors:  B S Schulz; S Kurz; K Weber; H-J Balzer; K Hartmann
Journal:  Vet J       Date:  2014-05-06       Impact factor: 2.688

7.  Seroprevalence of three influenza A viruses (H1N1, H3N2, and H3N8) in pet dogs presented to a veterinary hospital in Ohio.

Authors:  Hyesun Jang; Yasmine K Jackson; Joshua B Daniels; Ahmed Ali; Kyung-Il Kang; Mohamed Elaish; Chang-Won Lee
Journal:  J Vet Sci       Date:  2017-08-31       Impact factor: 1.672

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.